Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02176369Phase 2Completed
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial
Non-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV
PrincipalinvestigatorStart date: 2013-02-01

Research Network

Collaboration Network

23 collaborators·63 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

A.O. Santa Maria Degli Angeli - Pordenone

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Anna Paola Fraccon, MD

Casa di Cura Dott. Pederzoli - Peschiera del Garda

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Hector Soto Parra, MD

A. Ospedaliero-Universitaria Policlinico Vittorio Emanuele - Catania

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Luigi Cavanna, MD

AUSL Piacenza - Ospedale Guglielmo da Saliceto

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Mario Saverio Fumanò, MD

Ospedale Morelli - Sondalo

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Luciana Irtelli, MD

Ospedale Civile SS. Annunziata - Chieti

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Alessandro Bertolini, MD

A.O. Valtellina e Valchiavenna - Ospedale di Sondrio

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Daniele Pozzessere, MD

Azienda USL 4 Prato - O.C. Misericordia e Dolce

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Yasmina Modena, MD

Azienda Ulss18 - Ospedale S.M. della Misericordia - Rovigo

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Vittorio Gebbia, MD

Casa di Cura La Maddalena - Palermo

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Marco Platania, MD

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV

Worked with same sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRegione Lombardia
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02176369Phase 2PrincipalInvestigator

Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial

Non-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV
Completed

All 1 trials loaded